334 related articles for article (PubMed ID: 8778223)
1. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
Kineman RD; Gettys TW; Frawley LS
J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity.
Kineman RD; Gettys TW; Frawley LS
Endocrinology; 1994 Aug; 135(2):790-3. PubMed ID: 8033828
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine effects on in vitro responsiveness of anterior pituitary hormone release to dopamine and thyrotropin-releasing hormone in young female rats.
Moreno ML; Villanúa MA; Arce A; Esquifino AI
J Neuroendocrinol; 1995 Oct; 7(10):765-74. PubMed ID: 8563719
[TBL] [Abstract][Full Text] [Related]
4. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes.
Livingstone JD; Lerant A; Freeman ME
Neuroendocrinology; 1998 Sep; 68(3):172-9. PubMed ID: 9734001
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
Burris TP; Freeman ME
Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
[TBL] [Abstract][Full Text] [Related]
6. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
Larson GH; Koos RD; Sortino MA; Wise PM
Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
[TBL] [Abstract][Full Text] [Related]
7. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
Sortino MA; Wise PM
Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
[TBL] [Abstract][Full Text] [Related]
8. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
9. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
10. Effect of serotonin on basal and TRH-induced release of prolactin from rat pituitary glands in vitro.
Apfelbaum ME
Acta Endocrinol (Copenh); 1987 Apr; 114(4):565-71. PubMed ID: 3107298
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
Pu HF; Liu TC
J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
[TBL] [Abstract][Full Text] [Related]
12. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
Timmerman W; Poelman RT; Westerink BH; Schuiling GA
Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
Wang J; Ciofi P; Crowley WR
Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
[TBL] [Abstract][Full Text] [Related]
15. Contribution of arachidonate metabolites to basal and thyrotropin releasing-hormone-stimulated release of prolactin from purified lactotrophs in primary culture.
Junier MP; Israel JM; Dray F; Vincent JD
Life Sci; 1990; 47(20):1829-36. PubMed ID: 2124313
[TBL] [Abstract][Full Text] [Related]
16. The influence of oestrogen administration in vivo on in vitro prolactin release. Interaction between dopamine and thyrotrophin releasing hormone.
Jaques S; Gala RR
Acta Endocrinol (Copenh); 1979 Nov; 92(3):437-47. PubMed ID: 117662
[TBL] [Abstract][Full Text] [Related]
17. An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells.
Journot L; Homburger V; Pantaloni C; Priam M; Bockaert J; Enjalbert A
J Biol Chem; 1987 Nov; 262(31):15106-10. PubMed ID: 3117793
[TBL] [Abstract][Full Text] [Related]
18. In vitro release of prolactin by thyrotropin-releasing hormone: influence of dopamine, thyroxine, and cycloheximide.
Turpen C; Knigge KM
Horm Res; 1979; 11(3):128-41. PubMed ID: 114468
[TBL] [Abstract][Full Text] [Related]
19. Age-related alterations in prolactin secretion by individual cells as assessed by the reverse hemolytic plaque assay.
Larson GH; Wise PM
Biol Reprod; 1991 Apr; 44(4):648-55. PubMed ID: 1904281
[TBL] [Abstract][Full Text] [Related]
20. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro.
Fagin KD; Neill JD
Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
